84-4486-28 [取扱停止]BCAS2 200ul 386368
特徴
BCAS2 (breast carcinoma amplified sequence 2), also designated DAM1 (DNA amplified in mammary carcinoma 1 protein) or spliceosome-associated SPF 27, is a ubiquitously expressed nuclear protein that was originally identified as being overexpressed in various breast cancer cell lines.
BCAS2 is now known to be a component of the spliceosome, participating in the removal of introns from mRNA precursors.
BCAS2 specifically interacts (in a ligand-independent manner) with TR∫ (thyroid hormone receptor beta), ERå (estrogen receptor alpha), ER∫, PR (progesterone receptor), and PPAR© (Peroxisome proliferator-activated receptor gamma).
BCAS2 functions as an ER coactivator and is capable of enhancing ER-mediated transcription.
This suggests that BCAS2 is involved in the development of breast cancer.
Applications:Suitable for use in ELISA, Western Blot, Immunohistochemistry.
Other applications not tested.
Recommended Dilution:Western Blot: 1:200-1:1000Immunohistochemistry: 1:50-1:200Optimal dilutions to be determined by the researcher.
Storage and Stability:May be stored at 4°C for short-term only.
Aliquot to avoid repeated freezing and thawing.
Store at -20°C.
Aliquots are stable for 12 months after receipt.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
Size:200ul
Host:rabbit
Source Antibody:human
Grade:Affinity Purified
Purity:Purified by immunoaffinity chromatography.
Form:Supplied as a liquid in PBS, pH 7.3, 0.05% sodium azide, 50% glycerol.
Specificity:Recognizes human BCAS2. Species Crossreactivity: mouse
Isotype:IgG
Calc Applications Abbrev:E IHC WB
Calc Crossreactivity:Hu Mo
Immunogen:Recombinant protein corresponding to human BCAS2.
Shelf Life:1year
Swiss Prot Number:O75934
EU Commodity Code:30021010
この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
【試薬に関するお問合せ】
アズワン株式会社 試薬・プロセス材料グループ
TEL:06-6447-8641
FAX:06-6447-8642
E-mail:[email protected]